Full Text View
Tabular View
No Study Results Posted
Related Studies
Lamotrigine Versus Levetiracetam in the Initial Monotherapy of Epilepsy
This study has been completed.
Study NCT00242606   Information provided by Philipps University Marburg Medical Center

First Received on October 19, 2005.   Last Updated on May 8, 2012   History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Epilepsy
More general conditions related to this trial
Brain Diseases
Central Nervous System Diseases
Nervous System Diseases
Interventions listed in this trial
Lamotrigine
Levetiracetam
Additional drug interventions recognized in this trial
Etiracetam
Piracetam
More general drug interventions related to this trial
Anticonvulsants
Calcium Channel Blockers
Cardiovascular Agents
Central Nervous System Agents
Membrane Transport Modulators
Molecular Mechanisms of Pharmacological Action
Neuroprotective Agents
Nootropic Agents
Pharmacologic Actions
Physiological Effects of Drugs
Protective Agents
Therapeutic Uses
Sponsors listed in this trial
Philipps University Marburg Medical Center
UCB GmbH, Huettenstrasse 205, 50170 Kerpen, Germany


Contact Help Desk
Lister Hill National Center for Biomedical Communications,  U.S. National Library of Medicine,
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services